MedicaidPrior AuthMedium impact
Cosela™ (trilaciclib) (Revised)
Humana·IN · Oncology, Hematology·Medicaid
Effective date
Nov 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Indiana has established prior authorization requirements for Cosela (trilaciclib) injections, effective November 1, 2025. This cancer drug requires pre-approval for extensive-stage small cell lung cancer patients receiving specific chemotherapy regimens.
Action Required
By November 1, 2025: Oncology providers and billing staff must obtain prior authorization for all Cosela (trilaciclib) injections for Humana Medicaid Indiana members. Verify patient has extensive-stage small cell lung cancer diagnosis and is receiving platinum/etoposide or topotecan-containing chemotherapy regimens. Visit www.humana.com/PAL for specific billing codes and submit authorization requests before administration. Claims will be denied without prior approval.